
Mergers, Pricing, and New Technologies: The Top Health Issues of 2016
December 14, 2015.
According to PwC's Health Research Institute (HRI), 2016 will be a year of firsts for players within healthcare as the industry adapts to the main forces driving the New Health Economy: the rise of consumerism, the focus on value, downward pressure on costs, technological innovation and the impact of new entrants.
PwC's annual report, "
- Innovation: Mobile health technology will play more of a role in diagnosis and treatment, with new high-tech databases allowig industry players "to analyze data from many sources in novel ways, finally unlocking new insights."
- Access to care: More than half of US counties have no practicing mental health clinicians. Additionally, with mounting budget pressures, care may move to the community as health systems pursue lower-cost care settings more aggressively and creatively than before.
- The New Health Economy: Drug pricing will be in the spotlight and "providers may be scrambling to unlock the medical cost mystery and calculate the true cost of services". 2016 should also be a year in which the industry is dramatically reshaped by consolidation, as the insurance market should inch closer to being dominated by three major players.
"After more than a decade of identifying the top health industry trends, we are finally starting to see the creation of a New Health Economy – a health system that is more connected, transparent and patient-centric," said Kelly Barnes, PwC's US health industries leader. For more on the PwC report,
click here
.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.